Cipla informs about Press Release

23 Mar 2015 Evaluate

Cipla has informed regarding a Press Release dated March 23, 2015 titled 'Stempeutics receives Advanced Therapy Medicinal Product (ATMP) classification from European Medicines Agency (EMA) for its novel stem cell drug 'Stempeucel' '.

The above information is a part of company’s filings submitted to BSE.

Cipla Share Price

1424.40 4.85 (0.34%)
03-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1508.40
Dr. Reddys Lab 6332.85
Cipla 1424.40
Zydus Lifesciences 992.00
Lupin 1663.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.